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Abstract The association of patent foramen ovale (PFO)
and atrial septal aneurysm (ASA) with migraine headache
attack (MHA) has been clearly shown. The same findings
have been recently demonstrated also in cluster headache.
Although tension-type headaches (TTH) are the most
common kind of headache, their association with these
atrial septal abnormalities has never been studied before.
The study was conducted to clarify whether there was a
significant association between the presence of such atrial
septal abnormalities and tension headache, when com-
pared with migraineurs. One hundred consecutive patients
with migraine and 100 age- and sex-matched subjects with
TTH and 50 healthy volunteers with no headache were
enrolled in the study and underwent a complete trans-
esophageal echocardiographic study with contrast injec-
tions at rest and with the Valsalva maneuver. There was
no significant difference between the age and the sex of
the participants of the three groups. The overall preva-
lence of PFO was 23% in patients with TTH and that of
large PFOs was only 11%. The 23% prevalence of PFO in
patients with TTH was not statistically different from 16%
found in our normal control group. Furthermore, we found
a significantly higher prevalence of PFO in migraineurs
(50%) when compared with patients with tension head-
ache (p \ 0.001). This was also true for the collective
presence of large PFOs and ASAs (35%) (p \ 0.001).
Although atrial septal anomalies have an association with
MHA, they do not have a significant association with
TTH.
Keywords Tension-type headache  Migraine headache 
Patent foramen ovale  Atrial septal aneurysm
A. R. Moaref  K. Aghasadeghi  M. Zamirian 
M. B. Sharifkazemi  G. R. Rezaian (&)
Department of Medicine (Cardiology), Namazee Hospital,












Department of Medicine (Neurology),
Shiraz University of Medical Sciences, Shiraz, Iran
e-mail: petramfar@yahoo.com
S. Rezaian
Alzahra Cardiovascular Research Center,








Shiraz University of Medical Sciences, Shiraz, Iran
e-mail: najafzare@sums.ac.ir
123
J Headache Pain (2009) 10:431–434
DOI 10.1007/s10194-009-0154-y
Introduction
Several studies have shown an association between patent
foramen ovale (PFO) and migraine headache attack (MHA),
and that PFO is more common in migraineurs with aura [1]. In
addition, PFO and atrial septal aneurysm (ASA) have been
found to be an important risk factor for stroke [2]. A similar
association has recently been shown in patients with cluster
headache (CH) [3–5] raising the possibility that such atrial
septal abnormalities might play a role not only for migraine,
but also for other types of headache as well. Although tension-
type headaches (TTH) are the most common kind of headache
[6], their association with atrial septal abnormalities has never
been studied before. If these structural atrial septal abnor-
malities are predisposing conditions for different headache
disorders, then they should be also commonly found in sub-
jects with TTH or be at least as common as in patients with
MHA. This study, therefore, was designed to find out the
frequency and the association of atrial septal abnormalities
specifically PFOs and large PFOs with TTH and compare
them with the migraineurs and a group of normal subjects.
Materials and methods
Inclusion and exclusion criteria
Patients referring to our university hospital neurology head-
ache clinic were recruited. Only subjects aged 15 years and
older with headaches fulfilling the International Headache
Society Criteria for MHA (with or without aura) or TTH,
could properly answer the questions and accepted having
transesophageal echocardiography (TEE) were included.
Younger subjects, patients with medication overuse and those
not tolerating TEE or having insufficient echocardiographic
data (poor visualization of cardiac chambers and/or the atrial
septum) were excluded.
To exclude drug overuse, patients were asked for:
1. The type (NSAIDS, triptans, tricyclic antidepressants,
ergotamine, etc.), frequency and duration of the drugs
used for acute and/or symptomatic treatment of their
headaches and,
2. If their headache has had a very close temporal relation
to the use of their medications.
3. If there has been a marked aggravation of their
preexisting headache.
4. If they have definitely noted worsening of their
primary headache by the use of a specific drug.
All suspected cases were asked to stop the medication(s)
for 2 months and were reassessed afterwards for
improvement or resolution of their headache. Subjects were
included only after the exclusion of drug overuse headache.
The control subjects were included only when they had
neither migraine, TTH nor any other headache for at least
the past 6 months.
Patients and controls
From May 2007 to April 2009, 1,164 patients and 132
normal volunteers with an age range of 15–60 years were
visited. Information about migraine and tension headache
was obtained by a neurologist via a face-to-face interview
using a structured questionnaire. Drug overuse headache
was proved to be present in 674 subjects and 113 patients
had other headache types not fitting the study protocol. Of
remaining 394 patients who could be enrolled into the
study, 191 subjects had chronic TTH and 206 were mi-
graineurs. Following the exclusion of patients with no
interest for participation, refused to have TEE and/or could
not be age- and sex matched or had other exclusion criteria;
100 patients with migraine and 100 age- and sex-matched
subjects with chronic TTH and 50 healthy volunteers with
no headache in the last 6 months were enrolled in the
study. The control subjects were recruited from the family
members and friends of the study participants as well as
from those of patients referring to the cardiology clinics.
The aim and scope of the study were explained and TEE
was demonstrated. All had an interview with our neurolo-
gist to ensure fulfilling the study protocol. None of the
volunteers were paid for participation.
The diagnosis of the headaches was based on the
International Headache Society criteria, second edition [7].
All participants gave a written informed consent and the
study protocol was approved by the Institutional Ethics
Committee.
Transesophageal echocardiography
The echocardiographic instrument was Vivid 3 (GE Med-
ical Systems, WI, USA) in all subjects who underwent a
complete TEE study including color Doppler using a multi-
plane 6T, TEE probe.
The TEE study was done with the patient in the left
lateral decubitus position. Lidocaine spray was used for
topical anesthesia of the pharynx. After optimal visuali-
zation of all cardiac chambers and the atrial septum, con-
trast injections were done in the mid-esophageal short axis
and bicaval views in the 40–60 and 90–110 image
planes of the transducer, respectively.
Contrast medium
Two 10 ml syringes were used one containing 9 ml of
physiologic saline (0.9% NaCl) solution and the other
containing 1 ml of air. The contents of both syringes were
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rapidly mixed through a three-way stopcock until a
homogeneous solution was obtained. It was then rapidly
injected into a right antecubital vein through an 18-gauge
venous canula, while the patient was at rest. The exami-
nation was subsequently repeated with Valsalva maneuver.
The overall duration of Valsalva maneuver was 10 s. To
ensure a perfect procedure, all patients were trained to
perform the maneuver beforehand.
Severity of shunt
The shunting was considered small when 3–9 micro bub-
bles appeared in the left atrium (LA) either spontaneously
or after Valsalva maneuver and within three cardiac cycles
after the complete opacification of the right atrium by the
contrast medium [8]. The degree of shunting was defined as
medium or large with the presence of 10–30 or[30 micro
bubbles in the LA, respectively. A more than 4 mm sepa-
ration between septum primum and secundum was con-
sidered to be indicative of a large PFO.
Statistical analysis
Statistical analysis was performed using the Statistical
Package for Social Sciences (SPSS 15, Chicago, IL, USA).
Analysis of variance was used for mean age comparisons
and also v2 test was used as needed. A p value \0.05 was
considered significant.
Results
Demographic data of the three groups are shown in
Table 1. There was no significant difference between the
age and sex of the participants.
Females were predominant in all three groups (80%).
All patients with chronic TTH had attacks with a frequency
of C4 times per week. The overall prevalence of PFO was
23% in patients with TTH and that of large PFOs was only
11%.
In normal subjects, the frequency of PFOs and large
PFOs were 16 and 10%, respectively. These frequencies,
however, were not significantly higher in patients with TTH
compared with the normal subjects (odd’s ratio = 1.5, 95%
confidence interval [CI] 0.64–3.81, p = 0.318) and (odd’s
ratio = 1.11, [CI] 0.36–3.40, p = 0.852), respectively.
Aura was detected in 32% of patients with MHA. The
frequency of headache attacks ranged from B1 to over 5
headache days per month (once every 2 months to twice per
week), leading to activity restriction. Auras were visual in all
subjects. The frequency of PFO was 62.5% in aura-positive
patients and 44.1% in aura-negative subjects (p = 0.086),
while large PFOs were present in 53.1% of former group
compared with 26.5% of the latter one (p = 0.009).
PFOs and large PFOs were, however, much more pre-
valent in MHA patients than the normal control group
(odd’s ratio = 5.25, [CI] 2.24–12.30, p \ 0.001) and
(odd’s ratio = 4.85, [CI] 1.76–13.32, p = 0.001), respec-
tively. These atrial septal anomalies were significantly
more common in migraineurs than in TTH group (Table 2).
Discussion
Tension headache is the most common type of headache [6].
Migraine is also a common neurological disorder with an
overall prevalence of about 12% in the general population
[9]; on the other hand, PFO is a common cardiac finding as
well. In their large autopsy series of 965 normal hearts
Hagen et al. [10] found the prevalence of PFO to be 27%.
Table 1 Demographic data of
patients with TTH, MHA and
the control group
MHA migraine headache, n
number, TTH tension-type
headache
MHA (n = 100) TTH (n = 100) Control (n = 50) p value
Age (mean ± SD) 17–57 (34.6 ± 9.3) 15–60 (33.8 ± 10.4) 17–59 (32.1 ± 10.0) 0.352
Sex
Female 80 80 40 1
Male 20 20 10
Table 2 The prevalence of
PFOs and large PFOs/ASAs in
TTH patients versus
migraineurs
ASA atrial septal aneurysm, CI
confidence interval, MHA
migraine headache, n number,
OR odds ratio, PFO patent
foramen ovale, TTH tension-
type headache
TTH (n = 100) MHA (n = 100) OR (95% CI) p value
PFO
Negative (n and %) 77 (77%) 50 (50%) 3.35 (1.82–6.15) \0.001
Positive (n and %) 23 (23%) 50 (50%)
Large PFO/ASA
Negative (n and %) 89 (89%) 65 (65%) 4.36 (2.06–9.22) \0.001
Positive (n and %) 11 (11%) 35 (35%)
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In addition, recent data indicate a close association
between the presence of CH and atrial septal abnormalities
including PFO [3–5], raising the possibility of a cause and
effect relationship between these anomalies and different
types of headache. Our findings, however, showed that
there was no significant difference between the prevalence
of PFO in our patients with TTH when compared with
normal volunteers with no headache.
Furthermore, we found a significantly higher prevalence
of PFO in migraineurs when compared with patients with
tension headache (p \ 0.001) and the normal subjects. This
was also true for the collective presence of large PFOs and
ASAs (p \ 0.001).
Recent emerging data show an association between
MHA, especially those with aura and PFO [11]. Migraine
with aura is more strongly associated with larger shunts.
In their study of 400 patients, Wilmshurst et al. [12]
found that 53% of patients with large shunts had
migraine with aura, whereas only 25 and 4% of those
with medium and small shunts had these findings,
respectively.
Our findings also showed a strong association between
the presence of migraine headache and the presence of
large PFOs/ASAs. These anomalies were present in 35% of
MHA patients, while they were seen in only 11% of sub-
jects with TTH (p \ 0.001) and 10% of normal subjects.
This finding is important because ASAs have been impli-
cated as a potential source of embolic strokes and their
association with PFO could further increase the risk of
recurrent stroke in young adults [13].
Study limitations
There are some limitations in our study that include the
higher frequency of females in our three groups, the rela-
tively small number of the headache-free normal subjects
and inclusion of patients with only one type of TTH, i.e.
chronic tension headache.
Of course a large-scale study including all types of
tension headache and a larger number of headache-free
normal participants of all ages could solve some of these
limitations.
Measurement of type-II error was not preplanned in
present study and this is of course a shortcoming of this
study because assuming the percent difference of PFO
frequency between the tension headache patients and the
control group to be 7% (23–16%) with an a = 0.05, the
post hoc type-II error of the study would be 0.82.
Conclusion
The presence of atrial septal abnormalities does not have a
significant association with chronic tension headache and
their detection can neither be used for treatment plans nor
for clarification of pathogenetic mechanisms of the disease
when compared with migraineurs.
Conflict of interest None.
References
1. Schwedt TJ, Demaerschalk BM, Dodick DW (2008) Patent
foramen ovale and migraine: a quantitative systematic review.
Cephalalgia 28:531–540
2. Overell JR, Bone J, Lees KR (2000) Interatrial septal abnor-
malities and stroke: a meta-analysis of case–control studies.
Neurology 55:1172–1179
3. Finocchi C, Del Sette M, Angeli S, Rizzi D, Gandolfo C (2004)
Cluster headache and right-to-left shunt on contrast transcranial
Doppler: a case–control study. Neurology 63:1309–1310
4. Morelli N, Gori S, Cafforio G, Gallerini S, Baldacci F, Orlandi G,
Murri L (2005) Prevalence of right-to-left shunt in patients with
cluster headache. J Headache Pain 6:244–246
5. Dalla Volta G, Guindani M, Zavarise P, Griffini S, Pezzini A,
Padovani A (2005) Prevalence of patent foramen ovale in a large
series of patients with migraine with aura, migraine without aura
and cluster headache, and relationship with clinical phenotype.
J Headache Pain 6:328–330
6. Bigal ME, Lipton RB (2005) Tension-type headache: classifica-
tion and diagnosis. Curr Pain Headache Rep 9:423–429
7. Headache Classification Committee of the International Head-
ache Society (2004) The international classification of headache
disorders, 2nd edn. Cephalalgia 24(Suppl 1):1–160
8. Lamy C, Giannesini C, Zuber M, Arquizan C, Meder JF,
Trystram D, Coste J, Mas JL (2002) Clinical and imaging find-
ings in cryptogenic stroke patients with and without patent
foramen ovale. The PFO-ASA study. Stroke 33:706–711
9. Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ,
Stewart WF (2002) Migraine in the United States: epidemiology
and patterns of health care use. Neurology 58:885–894
10. Hagen PT, Scholz DG, Edwards WD (1984) Incidence and size of
patent foramen ovale during the first 10 decades of life: an
autopsy study of 965 normal hearts. Mayo Clin Proc 59:17–20
11. Sztajzel R, Genoud D, Roth S, Mermillod B, Le Floch-Rohr J
(2002) Patent foramen ovale, a possible cause of symptomatic
migraine: a study of 74 patients with acute ischemic stroke.
Cerebrovasc Dis 13:102–106
12. Wilmshurst PT, Nightingle S, Walsh KP, Morrison WL (2005)
Clopidogrel reduces migraine with aura after transcatheter clo-
sure of persistent foramen ovale and atrial septal defects. Heart
91:1173–1175
13. Berthet K, Lavergne T, Cohen A, Guize L, Bousser MG, Le
Heuzey JY (2000) Significant association of atrial vulnerability
with atrial septal abnormalities in young patients with atrial septal
abnormalities in young patients with ischemic stroke of unknown
cause. Stroke 31:398–403
434 J Headache Pain (2009) 10:431–434
123
